US OptionsDetailed Quotes
SNOW241213C104000
- 0.00
- 0.000.00%
15min DelayClose Dec 13 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest104.00Strike Price0.00Turnover0.00%IV-37.97%PremiumDec 13, 2024Expiry Date63.67Intrinsic Value100Multiplier-1DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma2.64Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Snowflake Stock Discussion
Sign in to post a comment
This unique biotech $Esperion Therapeutics (ESPR.US)$ Esperion has the only FDA approved statin alternative drugs NEXLIZET & NEXLETOL for Primary Prevention, Statins are a class of prescription drugs that help lower cholesterol levels. They are the most common treatment for high cholesterol, an estimated 21 Million Americans are Statin intolerant and or maxed out on Statin drugs and need additional lowering. Over 71 ...
+2
3
1
1
This unique biotech $Esperion Therapeutics (ESPR.US)$ Esperion has the only FDA approved statin alternative drugs NEXLIZET & NEXLETOL for Primary Prevention, Statins are a class of prescription drugs that help lower cholesterol levels. They are the most common treatment for high cholesterol, an estimated 21 Million Americans are Statin intolerant and or maxed out on Statin drug...
+2
1
Over the past few weeks, industry leaders like $Salesforce (CRM.US)$ , $Intuit (INTU.US)$ , and $Snowflake (SNOW.US)$ have showcased how Al is reshaping their offerings.
Cybersecurity firms are no exception, demonstrating that innovation in security is keeping pace with broader enterprise trends.
As Al shifts from hype to application, a pivotal moment has emerged. Autonomous Al agents are driving enterprise innovation, automating pro...
Cybersecurity firms are no exception, demonstrating that innovation in security is keeping pace with broader enterprise trends.
As Al shifts from hype to application, a pivotal moment has emerged. Autonomous Al agents are driving enterprise innovation, automating pro...
7
1
$Snowflake (SNOW.US)$ 159
we have to be every company that beat estimates that has a similar chart has already broken and it's going right back down to its moving average
we have to be every company that beat estimates that has a similar chart has already broken and it's going right back down to its moving average
4
The frenzy of artificial intelligence continues to soar. Recently, U.S. stock AI advertising marketing leader $Applovin (APP.US)$ have attracted global attention, with a stock price increase of over 850% since the beginning of the year, a market cap exceeding $127 billion, repeatedly hitting historic highs, and continuing the AI myth.
Read more: Why Are These AI Stocks Seeing Even Bigger Surges Than Nvidia This Year?
Citi has significantly increased its pric...
Read more: Why Are These AI Stocks Seeing Even Bigger Surges Than Nvidia This Year?
Citi has significantly increased its pric...
88
5
131
$Snowflake (SNOW.US)$ short this pig
2
1
.. gap above still needs to close!
No comment yet
10xStockPicks OP : This is the correctly edited research report. Previous article has a few typos. Special thanks to Fund manager John for his notes. Please do your own research. I firmly believe ESPR will be a solid bet.